Open access
Open access
Powered by Google Translator Translator

Ophthalmology

RCT | The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy.

17 Nov, 2022 | 12:11h | UTC

The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48-week randomized phase 4 study: STAR study – Acta Ophthalmologica

Commentary: Quarterly Dosing of Conbercept Similar to Treat-and-Extend Regimen for PCV – HCP Live

 


Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries.

10 Nov, 2022 | 13:32h | UTC

Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries – The Lancet Global Health

 

Commentary on Twitter

 


Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries.

10 Nov, 2022 | 13:31h | UTC

Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries – The Lancet Global Health

 

Commentary on Twitter

 


RCT | Effect of text messaging parents of school-aged children on outdoor time to control myopia.

9 Nov, 2022 | 12:26h | UTC

Effect of Text Messaging Parents of School-Aged Children on Outdoor Time to Control Myopia: A Randomized Clinical Trial – JAMA Pediatrics

 

Commentary on Twitter

 


RCT | Efficacy of an eye-tracking-based dichoptic home treatment for amblyopia.

8 Nov, 2022 | 12:04h | UTC

An eye-tracking-based dichoptic home treatment for amblyopia: a multicenter randomized clinical trial – Ophthalmology 

 


Recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis.

3 Nov, 2022 | 14:01h | UTC

Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis – The Journal of Rheumatology

 


SR | Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults.

3 Nov, 2022 | 13:40h | UTC

Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults – Cochrane Library

Summary: Treatment of inflammatory conditions of the eye with medications – Cochrane Library

 


Cohort Study | Association of retinal age gap with arterial stiffness and incident cardiovascular disease.

31 Oct, 2022 | 13:32h | UTC

Association of Retinal Age Gap With Arterial Stiffness and Incident Cardiovascular Disease – Stroke

Related:

Cohort Study | Artificial intelligence-enabled retinal vasculometry for prediction of cardiovascular diseases.

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.

Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.

 


Post-hoc analysis | Two-year visual field outcomes of the Treatment for Advanced Glaucoma Study (TAGS).

25 Oct, 2022 | 13:15h | UTC

Two-year visual field outcomes of the Treatment for Advanced Glaucoma Study (TAGS) – American Journal of Ophthalmology

Original study and commentary: Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.

 


Systematic Review | Topical corticosteroids for dry eye.

24 Oct, 2022 | 14:02h | UTC

Topical corticosteroids for dry eye – Cochrane Library

 


Systematic Review | TNF inhibitors for juvenile idiopathic arthritis‐associated uveitis.

21 Oct, 2022 | 12:55h | UTC

Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis – Cochrane Library

 


Cohort Study | Association of hyperopia with incident clinically significant depression.

20 Oct, 2022 | 12:18h | UTC

Association of hyperopia with incident clinically significant depression: epidemiological and genetic evidence in the middle-aged and older population – British Journal of Ophthalmology

Commentary: Older Individuals with Hyperopia More Likely to Develop Incident Depression – HCP Live

 


Cohort Study | Duration of diabetes and use of insulin are the most important predictors of diabetic retinopathy.

13 Oct, 2022 | 13:44h | UTC

Presence and development of diabetic retinopathy in 153 238 patients with type 2 diabetes in the Danish Registry of Diabetic Retinopathy – Acta Ophthalmologica

Commentary: Insulin Use May Predict the Development of Diabetic Retinopathy – HCP Live

 


RCT | Topical antibiotics reduce the time to clinical cure in children with infective conjunctivitis.

5 Oct, 2022 | 13:55h | UTC

Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis – JAMA Network Open

Commentaries:

Topical Antibiotics Linked With Reduced Duration of Acute Infective Conjunctivitis in Children – AJMC

Topical Antibiotics Shorten Duration of Conjunctival Symptoms – HealthDay

 

Commentary on Twitter

 


Cohort Study | Artificial intelligence-enabled retinal vasculometry for prediction of cardiovascular diseases.

5 Oct, 2022 | 13:53h | UTC

Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke – British Journal of Ophthalmology

Editorial: The eyes as a window to the heart: looking beyond the horizon – British Journal of Ophthalmology

Commentary: AI eye checks can predict heart disease risk in less than minute, finds study – The Guardian

Related:

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.

Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.

 


RCT | Doxycycline vs. placebo in patients with mild thyroid-associated ophthalmopathy.

30 Sep, 2022 | 12:35h | UTC

Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)

Invited commentary: Oral Doxycycline for Mild Thyroid Eye Disease – JAMA Opthalmology (free for a limited period)

 


RCT | Cyclosporine A (0.05%) ophthalmic gel in the treatment of dry eye disease.

28 Sep, 2022 | 13:42h | UTC

Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial – Drug Design, Development and Therapy

 


RCT | 6-year results of primary selective laser trabeculoplasty vs. eye drops for glaucoma and ocular hypertension.

23 Sep, 2022 | 13:06h | UTC

LiGHT trial: 6-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension – Ophthalmology

Original Study: Randomized Trial: Selective Laser Trabeculoplasty vs. Eye Drops for First-line Treatment of Ocular Hypertension and Glaucoma

 


RCT | Myopia control effect of repeated low-level red-light therapy in children.

20 Sep, 2022 | 13:31h | UTC

Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial – Ophthalmology

Commentary: Repeated Low-Level Red-Light Therapy Reduces Myopia Progression in Children – HCP Live

 


RCT | Patient preference and treatment satisfaction with a port delivery system for Ranibizumab vs. intravitreal injections in patients with neovascular age-related macular degeneration.

30 Aug, 2022 | 12:06h | UTC

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial – JAMA Ophthalmology

Commentary: Port Delivery System Preferred Over Intravitreal Injection for Patients with nAMD – HCPLive

 

Commentary on Twitter

 


Consensus Recommendations | Diagnosis, management, and treatment of vernal keratoconjunctivitis.

26 Aug, 2022 | 13:21h | UTC

Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group – Frontiers in Medicine

 


Cohort analysis of the relationship between intraoperative complications of cataract surgery and axial length.

24 Aug, 2022 | 13:57h | UTC

Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 8, cohort analysis of the relationship between intraoperative complications of cataract surgery and axial length – BMJ Open

 


Cluster RCT | Effect of biannual mass azithromycin distributions to preschool-aged children on trachoma prevalence.

24 Aug, 2022 | 13:55h | UTC

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


RCT | Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension.

11 Aug, 2022 | 11:57h | UTC

Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study – Acta Ophthalmologica

Commentary: Topical Dexamethasone Ophthalmic Suspension OCS-01 Effective in DME Treatment – HCP Live

 


Systematic Review | Laser trabeculoplasty for open‐angle glaucoma and ocular hypertension.

10 Aug, 2022 | 12:28h | UTC

Laser trabeculoplasty for open‐angle glaucoma and ocular hypertension – Cochrane Library

Summary: Laser trabeculoplasty for open-angle glaucoma – Cochrane Library

Related Study: Randomized Trial: Selective Laser Trabeculoplasty vs. Eye Drops for First-line Treatment of Ocular Hypertension and Glaucoma

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.